Werbung
Werbung

SLXN

SLXN logo

Silexion Therapeutics Corp Ordinary Shares

2.12
USD
Gesponsert
+0.02
+0.95%
09. Jan., 15:12 UTC -5
Geschlossen
exchange

Nach-Markt

2.09

-0.03
-1.60%

SLXN Ergebnisberichte

Positives Überraschungsverhältnis

SLXN übertreffen die 2 der letzten 5Schätzungen.

40%

Nächster Bericht

Datum des nächsten Berichts
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q-- -1 (Revenue/ EPS)
--
/
--

Silexion Therapeutics Corp Ordinary Shares earnings per share and revenue

On 12. Nov. 2025, SLXN reported earnings of -2.88 USD per share (EPS) for Q3 25, beating the estimate of -3.46 USD, resulting in a 16.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +3.56% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, Silexion Therapeutics Corp Ordinary Shares reported EPS of -$2.88, beating estimates by 16.96%, and revenue of $0.00, 0% as expectations.
The stock price moved up 3.56%, changed from $2.81 before the earnings release to $2.91 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Silexion Therapeutics Corp Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung